Breadcrumb Home Studies Studies Search Filter Research Area AllBrain and Mental HealthCure and ImmunotherapyTherapeuticsTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentOpen to AccrualParticipants Off Study and Primary Analysis CompletedWithdrawn Sort Study Number AscStudy Number Desc Submit Search Showing 14 studies. P1113: AERAS-404 TB Vaccine in BCG-Primed Infants DAIDS Number 11911 Research Area Tuberculosis Study Status Concluded P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV. DAIDS Number 11884 Research Area Tuberculosis P1100: AERAS 402 DAIDS Number 11801 Research Area Tuberculosis Study Status Concluded P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis Pagination Previous page Prev Page 1 Current page 2
P1113: AERAS-404 TB Vaccine in BCG-Primed Infants DAIDS Number 11911 Research Area Tuberculosis Study Status Concluded
P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV. DAIDS Number 11884 Research Area Tuberculosis
P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis
